Exelixis

Exelixis

EXEL· Manufacturing· Market cap · Fiscal year ends in January

CEO pay in FY2025Stock +52.3% in FY2025

Michael M. Morrissey is the CEO of Exelixis and was paid $33.2M in FY2025 (Jan), up 161%.

Pay$100 in the stock at the end of FY21 → $149
CEO pay is from each Exelixis proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives7

See all
  1. 1Michael M. MorrisseyFY2025
  2. 2Amy C. Peterson, M.D.FY2025
  3. 3Christopher J. SennerFY2025
  4. 4Patrick J. HaleyFY2025
  5. 5Jeffrey J. Hessekiel, J.D.FY2025
  6. 6Dana T. Aftab, Ph.D.FY2024

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Exelixis paid its 5 named executives $73.0M in total in FY2025 (Jan). CEO Michael M. Morrissey was paid $33.2M of that.

Name
Michael M. MorrisseyPresident and Chief Executive Officer
Amy C. Peterson, M.D.Former Executive Vice President, Medical Affairs, and Chief Medical OfficerNot disclosed
Christopher J. SennerExecutive Vice President and Chief Financial Officer
Patrick J. HaleyExecutive Vice President, CommercialNot disclosedNot disclosed
Jeffrey J. Hessekiel, J.D.Former Executive Vice President, General Counsel
Dana T. Aftab, Ph.D.Executive Vice President, Research and DevelopmentNot disclosedNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers17

See all

The FY2025 (Jan) proxy of Exelixis names 17 peer companies for pay. Among Exelixis and these peers, CEO pay was the highest of 10 and total shareholder return was 4th highest of 10.

1st highest of 10in Exelixis and its pay peers, FY2025 (Jan) by CEO pay:

$6.9M$33.2M

4th highest of 10in Exelixis and its pay peers, FY2025 (Jan) by total shareholder return:

$68$321

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Activity

Filings7

See all
Proxy statementDEF 14AApr 15, 2026FY2025
Annual report10-KFeb 10, 2026FY2025
Proxy statementDEF 14AApr 16, 2025FY2024
Annual report10-KFeb 11, 2025FY2024
Proxy statementDEF 14AApr 18, 2024FY2023
Annual report10-KFeb 6, 2024FY2023